Investment Summary |
|
---|---|
Date | 2014-11-06 |
Target | Nevro |
Sector | Medical Products |
Sellers(s) |
Bay City Capital
Three Arch Partners |
Deal Type | IPO |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Venture Capital Firm |
---|---|
Founded | 1997 |
PE ASSETS | 1.3B USD |
Size | Large |
Type | Sector Focused |
Bay City Capital LLC was established in 1997 as an equal partnership between The Craves Group and certain Pritzker family business interests for the purpose of managing investment funds in the life sciences industry. Bay City looks for opportunities at all stages of development in biopharmaceuticals, drug discovery, medical devices and diagnostics. Bay City Capital is based in San Francisco, California.
DEAL STATS | # |
---|---|
Overall | 54 of 62 |
Sector (Medical Products) | 10 of 10 |
Type (IPO) | 22 of 23 |
State (California) | 29 of 33 |
Country (United States) | 52 of 59 |
Year (2014) | 6 of 6 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2014-10-24 |
Aciex Therapeutics
Boston, Massachusetts, United States Aciex Therapeutics, Inc. is an ophthalmic pharmaceutical company centered on developing first in class products to treat ocular diseases. |
Sell | $120M |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2015-10-20 |
Merus BV
Utrecht, Netherlands Merus BV is a fully-integrated biotechnology company developing cancer therapeutics that combine the benefits of monoclonal antibodies with the ability of simultaneously addressing multiple targets. |
Sell | - |
Category | Private Equity Firm |
---|---|
Founded | 1993 |
PE ASSETS | 1.0B USD |
Size | Large |
Type | Sector Agnostic |
Three Arch Partners is an investor in healthcare companies, including medical devices, diagnostics, and healthcare services. Three Arch primarily invests in early stage companies, however the Firm will consider select later stage investments. Three Arch typically invests alongside others and looks to commit $100k to $15 million per investment. Three Arch Partners was formed in 1993 and is based in San Mateo, California.
DEAL STATS | # |
---|---|
Overall | 20 of 24 |
Sector (Medical Products) | 13 of 14 |
Type (IPO) | 6 of 6 |
State (California) | 16 of 17 |
Country (United States) | 20 of 24 |
Year (2014) | 4 of 5 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2014-05-12 |
AccessClosure
Santa Clara, California, United States AccessClosure, Inc. is a medical device company that is pioneering innovative access site management products designed to address the complex challenge of vascular closure during interventional and diagnostic procedures. |
Sell | $320M |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2014-11-12 |
Centerre Healthcare
Brentwood, Tennessee, United States Centerre Healthcare is a provider of physical rehabilitation. Centerre Healthcare has the experience and resources to create highly successful rehabilitation hospitals while meeting the clinical and financial requirements of its partner hospitals. |
Sell | $195M |